An Identification Scheme for Rapidly and Aerobically Growing Gram-positive Rods*

https://doi.org/10.1016/S0934-8840(96)80100-9Get rights and content

Summary

An identification scheme for aerobically growing Gram-positive rods (generaActinomyces, Arcanobacterium, Aureobacterium, Bacillus, Brevibacterium, Cellulomonas, Corynebacterium, Dermabacter, Erysipelothrix, Gardnerella, Lactobacillus, Listeria, Microbacterium, Oerskovia, Propionibacterium, Rhodococcus, Rothia, Turicella, as well as unnamed CDC groups, Clostridium tertium, and Mycobacterium fortuitum/chelonae) is presented. It is derived from the Hollis-Weaver scheme and uses catalase, oxidative/fermentative carbohydrate metabolism and motility as primary reactions. Tests for lipophilism, nitrate reduction, urease, esculin hydrolysis, the CAMP reaction, acid formation from five carbohydrates, as well as for some facultative reactions should lead to a correct diagnosis based on information available at the end of 1995.

References (33)

  • P.J.H. Jackman et al.

    Classification of corynebacteria associated with endocarditis (group JK) as Corynebacterium jeikeium sp

    nov. Syst. Appl. Microbiol.

    (1987)
  • M. Neubauer et al.

    Corynebacterium accolens sp. nov., a Gram-positive rod exhibiting satellitism, from clinical material

    Syst. Appl. Microbiol

    (1991)
  • P. Riegel et al.

    Proposal of Corynebacterium propinquum sp

    nov. for Corynebacterium group ANF-3 strains. FEMS Microbiol. Lett.

    (1993)
  • C. Barreau et al.

    Comparative chemotaxonomic studies of mycolic acid-free coryneform bacteria of human origin

    J. Clin. Microbiol.

    (1993)
  • G.M. Carlone et al.

    Methods for distinguishing Grampositive from Gram-negative bacteria

    J. Clin. Microbiol.

    (1983)
  • D. de Briel et al.

    High-performance liquid chromatography of corynomycolic acids as a tool in identification of Corynebacterium species and related organisms

    J. Clin. Microbiol.

    (1992)
  • G. Funke et al.

    Corynebacterium glucuronolyticum sp

    nov. isolated from male patients with genitourinary infections. Med. Microbiol. Lett.

    (1995)
  • G. Funke et al.

    Differentiation of Brevibacterium spp

    encountered in clinical specimens. J. Clin. Microbiol.

    (1994)
  • G. Funke et al.

    Primary identification of Microbacterium spp

    encountered in clinical specimens as CDC coryneform group A-4 and A-5 bacteria. J. Clin. Microbiol.

    (1995)
  • G. Funke et al.

    Most Corynebacterium xerosis strains identified in the routine clinical laboratory correspond to Corynebacterium amycolatum

    J. Clin. Microbiol.

    (1996)
  • G. Funke et al.

    Heterogeneity within Centers for Disease Control and Prevention coryneform group ANF-1-like bacteria and description of Corynebacterium auris sp

    nov. Int. J. Syst. Bacteriol.

    (1995)
  • G. Funke et al.

    Identification of some clinical strains of CDC corvneform group A-3 and group A-4 bacteria as Cellulomonas species and proposal of Cellulomonas hominis sp

    nov. for some group A-3 strains. J. Gun. Microbiol.

    (1995)
  • G. Funke et al.

    Description of human-derived Centers for Disease Control coryneform group 2 bacteria as Actinomyces bernardiae sp

    nov. Int. J. Syst. Bacteriol.

    (1995)
  • G. Funke et al.

    Turicella otitidis gen

    nov. sp. nov., a coryneform bacterium isolated from patients with otitis media. Int. J. Syst. Bacteriol.

    (1994)
  • G. Funke et al.

    Characteristics of CDC group 3 and group 5 coryneform bacteria isolated from clinical specimens and assignment to the genus Dermabacter

    J. Clin. Microbiol.

    (1994)
  • G. Funke et al.

    Assignment of humanderived CDC group 1 coryneform bacteria and CDC group 1-like coryneform bacteria to the genus Actinomyces as Actinomyces neuii subsp. neuii sp

    nov., subsp. nov., and Actinomyces neuii subsp. anitratus subsp. nov. Int. J. Syst. Bacteriol.

    (1994)
  • Cited by (0)

    *

    Dedicated to Prof. Dr. H. Brandis on the occasion of his 80th birthday.

    *

    Prof. Dr. Alexander von Graevenitz, Institut für Med. Mikrobiologie der Universität Zürich, Gloriastraße 30/32, Postfach, CH-8028 Zürich, Schweiz

    View full text